Literature DB >> 28512033

Bifidobacterium CECT 7765 modulates early stress-induced immune, neuroendocrine and behavioral alterations in mice.

A Moya-Pérez1, A Perez-Villalba2, A Benítez-Páez1, I Campillo1, Y Sanz3.   

Abstract

Emerging evidence suggests that there is a window of opportunity within the early developmental period, when microbiota-based interventions could play a major role in modulating the gut-brain axis and, thereby, in preventing mood disorders. This study aims at evaluating the effects and mode of action of Bifidobacterium pseudocatenulatum CECT 7765 in a murine model of chronic stress induced by maternal separation (MS). C57Bl/6J male breast-fed pups were divided into four groups, which were subjected or not to MS and supplemented with placebo or B. pseudocatenulatum CECT7765 until postnatal period (P) 21 and followed-up until P41. Behavioral tests were performed and neuroendocrine parameters were analyzed including corticosterone, cytokine/chemokine concentrations and neurotransmitters. Microbiota was also analyzed in stools by 16S rRNA gene sequencing. B. pseudocatenulatum CECT 7765 administration attenuated some aspects of the excessive MS-induced stress response of the hypothalamic-pituitary-adrenal (HPA) axis, particularly corticosterone production at baseline and in response to subsequent acute stress in adulthood. B. pseudocatenulatum CECT 7765 also down-regulated MS-induced intestinal inflammation (reducing interferon gamma [IFN-γ]) and intestinal hypercatecholaminergic activity (reducing dopamine [DA] and adrenaline [A] concentrations) at P21. These effects have a long-term impact on the central nervous system (CNS) of adult mice since MS mice fed B. pseudocatenulatum CECT 7765 showed lower anxiety levels than placebo-fed MS mice, as well as normal neurotransmitter levels in the hypothalamus. The anti-inflammatory effect of B. pseudocatenulatum CECT 7765 seemed to be related to an improvement in glucocorticoid sensitivity in mesenteric lymph node immunocompetent cells at P21. The administration of B. pseudocatenulatum CECT 7765 to MS animals also reversed intestinal dysbiosis affecting the proportions of ten Operational Taxonomic Units (OTUs) at P21, which could partly explain the restoration of immune, neuroendocrine and behavioral alterations caused by stress in early and later life. In summary, we show that B. pseudocatenulatum CECT 7765 is able to beneficially modulate the consequences of chronic stress on the HPA response produced by MS during infancy with long-lasting effects in adulthood, via modulation of the intestinal neurotransmitter and cytokine network with short and long-term consequences in brain biochemistry and behavior.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Bifidobacterium; Depression; Inflammation; Neurotransmitters; Stress

Mesh:

Substances:

Year:  2017        PMID: 28512033     DOI: 10.1016/j.bbi.2017.05.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  38 in total

Review 1.  The microbiota-gut-brain axis: An emerging role for the epigenome.

Authors:  Tijs Louwies; Anthony C Johnson; Albert Orock; Tian Yuan; Beverley Greenwood-Van Meerveld
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-05

2.  Pharmacological restoration of gut barrier function in stressed neonates partially reverses long-term alterations associated with maternal separation.

Authors:  Marion Rincel; Maïwenn Olier; Amandine Minni; Camille Monchaux de Oliveira; Yann Matime; Eric Gaultier; Isabelle Grit; Jean-Christophe Helbling; Anna Maria Costa; Amandine Lépinay; Marie-Pierre Moisan; Sophie Layé; Laurent Ferrier; Patricia Parnet; Vassilia Theodorou; Muriel Darnaudéry
Journal:  Psychopharmacology (Berl)       Date:  2019-05-23       Impact factor: 4.530

3.  Bifidobacterium pseudocatenulatum CECT 7765 Ameliorates Neuroendocrine Alterations Associated with an Exaggerated Stress Response and Anhedonia in Obese Mice.

Authors:  Ana Agusti; A Moya-Pérez; I Campillo; S Montserrat-de la Paz; V Cerrudo; A Perez-Villalba; Yolanda Sanz
Journal:  Mol Neurobiol       Date:  2017-09-18       Impact factor: 5.590

Review 4.  Childhood adversity and mechanistic links to hypertension risk in adulthood.

Authors:  Ijeoma E Obi; Kasi C McPherson; Jennifer S Pollock
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

Review 5.  Do your gut microbes affect your brain dopamine?

Authors:  Camila González-Arancibia; Jocelyn Urrutia-Piñones; Javiera Illanes-González; Jonathan Martinez-Pinto; Ramón Sotomayor-Zárate; Marcela Julio-Pieper; Javier A Bravo
Journal:  Psychopharmacology (Berl)       Date:  2019-05-17       Impact factor: 4.530

6.  Prenatal Isoflurane Exposure Induces Developmental Neurotoxicity in Rats: the Role of Gut Microbiota.

Authors:  Li-Kuan Wang; Xu-Dong Yang; Dan Zhou; Tong Cheng; Xiang Zhang; Hai-Yin Wu
Journal:  Neurotox Res       Date:  2022-03-16       Impact factor: 3.911

Review 7.  Gut microbiome in neuroendocrine and neuroimmune interactions: The case of genistein.

Authors:  Tai L Guo; Yingjia Chen; Hannah Shibo Xu; Callie M McDonough; Guannan Huang
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-14       Impact factor: 4.219

Review 8.  Pro-biomics: Omics Technologies To Unravel the Role of Probiotics in Health and Disease.

Authors:  Despoina Eugenia Kiousi; Marina Rathosi; Margaritis Tsifintaris; Pelagia Chondrou; Alex Galanis
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

9.  A Meta-analysis of Gut Microbiota in Children with Autism.

Authors:  Pedro Andreo-Martínez; María Rubio-Aparicio; Julio Sánchez-Meca; Alejandro Veas; Agustín Ernesto Martínez-González
Journal:  J Autism Dev Disord       Date:  2021-05-05

10.  Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male Rats.

Authors:  M E Glover; J L Cohen; J R Singer; M N Sabbagh; J R Rainville; M T Hyland; C D Morrow; C T Weaver; G E Hodes; Ilan A Kerman; S M Clinton
Journal:  Neuroscience       Date:  2021-02-01       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.